Advertisement

Topics

Intersect ENT, Inc. ' Company Profile

06:23 EDT 26th June 2019 | BioPortfolio

Intersect ENT, Inc. is dedicated to improving the quality of life for patients with ear, nose and throat conditions. The company markets two steroid releasing implants, PROPEL and PROPEL mini, clinically proven to improve surgical outcomes for patients with chronic sinusitis undergoing ethmoid sinus surgery. In addition, Intersect ENT is developing new steroid releasing implants designed to provide ENT physicians with even more customized options to treat patients with chronic sinusitis less invasively and more cost effectively. Chronic sinusitis is an inflammatory condition leading to debilitating symptoms and chronic infections, and is one of the most costly conditions to U.S. employers.


News Articles [22 Associated News Articles listed on BioPortfolio]

CMS grants preliminary reimbursement to Intersect ENT's sinus implant

Intersect ENT has obtained preliminary J-code reimbursement for its Sinuva corticosteroid-eluting sinus implant, which delive -More- 

Intersect ENT to Present at the 37th Annual J.P. Morgan Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at the...

Intersect ENT to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will participate in the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at th...

Intersect ENT to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will participate in the 2019 Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, 2019 at th...

Intersect ENT to Report First Quarter 2019 Financial Results

Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will release first quarter ...

Intersect ENT to Report Fourth Quarter and Year 2018 Financial Results

Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release fourth...

Intersect ENT Reports Preliminary Fourth Quarter and Full Year 2018 Revenue

Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported preliminary unaudit...

Intersect ENT (XENT) Presents at Annual 2019 JP Morgan Healthcare Conference - Slideshow

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Sinuva [intersect ent, inc.]

These highlights do not include all the information needed to use SINUVA™ safely and effectively. See full prescribing information for SINUVA. SINUVA (mometasone furoate) sinus implantInitial U.S. A...

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

Contraception.

Contraception counseling and provision are vital components of comprehensive health care. Unplanned pregnancy can be devastating to any woman but is particularly dangerous for those with chronic illne...

Race/ethnicity, nativity, and lifetime risk of mental disorders in US adults.

There has been no comprehensive examination of how race/ethnicity and nativity intersect in explaining differences in lifetime prevalence of mental disorders among Asian, Black, Latino, and White adul...

Adolescent-led marriage in Somaliland and Putland: A surprising interaction of agency and social norms.

Child marriage, formal and informal unions when one or both spouses are under 18, disproportionately affects adolescent girls over boys. It has serious consequences for girls' health, wellbeing, and d...

Determination of the quantitative content of lipids in a biological material by the method of IR spectroscopy.

A modification of the Folch method has been proposed for the quantitative determination of lipids in biological material, in which, after extraction of lipids with a chloroform / ethanol mixture, lipi...

The labyrinth unfolds: architectural rearrangements of the endolysosomal system in antigen-presenting cells.

Antigen-presenting cells (APCs) capture and present pathogens to T cells, thus arousing adaptive immune responses geared at the elimination of these invaders. In APCs, pathogens acquired from the extr...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Traditional Chinese Medicine for Treatment of Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a prevalent condition that adversely affects patient's quality of life and represents a large health care burden globally. Currently, there is no satisfac...

Companies [4 Associated Companies listed on BioPortfolio]

Intersect ENT Inc.

Intersect ENT Inc. (www.IntersectENT.com) is a medical device company that is pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. ...

Intersect ENT, Inc.

Intersect ENT Inc., located in Palo Alto, Calif., is an innovator in local drug delivery focused on advancing clinically proven therapy solutions that improve quality of life for ...

Intersect ENT, Inc. '

Intersect ENT, Inc. is dedicated to improving the quality of life for patients with ear, nose and throat conditions. The company markets two steroid releasing implants, PROPEL and...

EMBA Medical Limited

EMBA Medical™ Limited is a Dublin, Ireland, domiciled medical device company that designs and develops innovative peripheral embolization technologies focused on improving sa...

More Information about "Intersect ENT, Inc. '" on BioPortfolio

We have published hundreds of Intersect ENT, Inc. ' news stories on BioPortfolio along with dozens of Intersect ENT, Inc. ' Clinical Trials and PubMed Articles about Intersect ENT, Inc. ' for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intersect ENT, Inc. ' Companies in our database. You can also find out about relevant Intersect ENT, Inc. ' Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...


Corporate Database Quicklinks



Searches Linking to this Company Record